194 related articles for article (PubMed ID: 29031319)
1. Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.
Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song H
Eur J Oncol Nurs; 2017 Oct; 30():84-90. PubMed ID: 29031319
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
3. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.
Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Burney S
Psychooncology; 2013 Oct; 22(10):2169-76. PubMed ID: 23483679
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life and Its Associated Factors in Prostate Cancer Patients Who Receive Androgen Deprivation Therapy.
Chien CH; Chuang CK; Liu KL; Wu CT; Pang ST; Chang YH
Cancer Nurs; 2021; 44(1):E34-E42. PubMed ID: 31743152
[TBL] [Abstract][Full Text] [Related]
5. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
[TBL] [Abstract][Full Text] [Related]
7. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
Lubeck DP; Grossfeld GD; Carroll PR
Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Nelson AM; Gonzalez BD; Jim HS; Cessna JM; Sutton SK; Small BJ; Fishman MN; Zachariah B; Jacobsen PB
Support Care Cancer; 2016 Oct; 24(10):4159-66. PubMed ID: 27142516
[TBL] [Abstract][Full Text] [Related]
10. Impact of Androgen Deprivation Therapy on Self-Reported Cognitive Function in Men with Prostate Cancer.
Marzouk S; Naglie G; Tomlinson G; Duff Canning S; Breunis H; Timilshina N; Alibhai SMH
J Urol; 2018 Aug; 200(2):327-334. PubMed ID: 29477720
[TBL] [Abstract][Full Text] [Related]
11. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.
Benedict C; Traeger L; Dahn JR; Antoni M; Zhou ES; Bustillo N; Penedo FJ
J Sex Med; 2014 Oct; 11(10):2571-80. PubMed ID: 25059094
[TBL] [Abstract][Full Text] [Related]
12. Information needs of men on androgen deprivation therapy.
Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
[TBL] [Abstract][Full Text] [Related]
13. Bone health and its correlates in Korean prostate cancer patients receiving androgen deprivation therapy.
Kim SH; Seong do H; Yoon SM; Choi YD; Song Y; Song H; Choi E
Eur J Oncol Nurs; 2016 Apr; 21():197-204. PubMed ID: 26522218
[TBL] [Abstract][Full Text] [Related]
14. Association of stress management skills and perceived stress with physical and emotional well-being among advanced prostrate cancer survivors following androgen deprivation treatment.
Penedo FJ; Benedict C; Zhou ES; Rasheed M; Traeger L; Kava BR; Soloway M; Czaja S; Antoni MH
J Clin Psychol Med Settings; 2013 Mar; 20(1):25-32. PubMed ID: 22739661
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
[TBL] [Abstract][Full Text] [Related]
16. Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial.
Baguley BJ; Skinner TL; Jenkins DG; Wright ORL
Clin Nutr; 2021 Jan; 40(1):245-254. PubMed ID: 32534948
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
[TBL] [Abstract][Full Text] [Related]
18. Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N; Zhu Y; Han DY; Lange K; Zhu S; Wang A; Ellett S; Masters J; Goudie M; Keogh J; Benjamin B; Holmes M; Ferguson LR
BMC Urol; 2016 Aug; 16(1):48. PubMed ID: 27485119
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health-related quality of life in lung cancer survivors.
Jung JY; Lee JM; Kim MS; Shim YM; Zo JI; Yun YH
Psychooncology; 2018 Feb; 27(2):465-470. PubMed ID: 28755492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
